874196-43-7

Basic information

• Product Name: 2,5,9,12-Tetraazatridecanedioic acid, 5,9-bis[(1,1-dimethylethoxy)carbonyl]-7-[2-(phenylmethoxy)ethyl]-, bis(1,1-dimethylethyl) ester
• CAS NO: 874196-43-7
• Molecular Formula: C36H62N4O9
• Molecular Weight: 694.91
• Mol File: 874196-43-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2,5,9,12-Tetraazatridecanedioic acid, 5,9-bis[(1,1-dimethylethoxy)carbonyl]-7-[2-(phenylmethoxy)ethyl]-, bis(1,1-dimethylethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5,9,12-Tetraazatridecanedioic acid, 5,9-bis[(1,1-dimethylethoxy)carbonyl]-7-[2-(phenylmethoxy)ethyl]-, bis(1,1-dimethylethyl) ester(874196-43-7)
• EPA Substance Registry System: 2,5,9,12-Tetraazatridecanedioic acid, 5,9-bis[(1,1-dimethylethoxy)carbonyl]-7-[2-(phenylmethoxy)ethyl]-, bis(1,1-dimethylethyl) ester(874196-43-7)

Safety Data

• Hazardous Substances Data: 874196-43-7(Hazardous Substances Data)

Upstream product

• 41478-45-9 Diethyl<(2-benzyloxy)ethyl>malonate 
• 874196-41-5 N,N'-bis-(2-aminoethyl)-2-(2-benzyloxy-ethyl)malonamide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 874196-42-6 N,N'-bis(2-amino-ethyl)-2-(2-benzyloxyethyl)-1,3-diaminopropane 

Relevant articles and documents

APOPTOSIS IMAGING AGENTS BASED ON LANTIBIOTIC PEPTIDES

The present invention relates to radiopharmaceutical imaging in vivo of apoptosis. The invention provides imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. The radiopharmaceuticals comprise radiometal complexes of chelator conjugates of PE-binding peptides. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.